Maroc - Post-traumatic stress disorder (PTSD) can cause an array of adverse mental health effects, but physical side effects are also common.
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Rubriques :
US: FDA says no to pyschedlic MDMA as PTSD treatment
A US company seeking to use MDMA capsules to treat post-traumatic stress disorder has said federal regulators rejected the bid. Lykos Therapeutics said the FDA requested an additional Phase 3 trial to gather more data.
Articles similaires
Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome
pharmabiz.com - 04/Sep 00:00
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome
pharmabiz.com - 04/Sep 00:00
Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...
Ketamine clinics show inconsistent practices on pregnancy and contraception
news.medical.net - 04/Sep 02:52
More hospitals and clinics now offer patients ketamine therapy for severe depression, post-traumatic stress disorder and other mental health...
Relief Therapeutics presents PKU GOLIKE study results at SSIEM 2024
pharmabiz.com - 03/Sep 00:00
Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...
First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma
drugs.com - 09/Sep 20:09
HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...
Canadian soldier successfully completes fourth Prairie Thousand charity bike ride
moosejawtoday.com - 04/Sep 20:31
From Aug. 11 to 19, Sgt. Rob Nederlof pedalled the highways between Edmonton and Regina on his bike. This was the fourth year for the ride, which...
Canadian soldier successfully completes fourth Prairie Thousand charity bike ride
moosejawtoday.com - 04/Sep 20:31
From Aug. 11 to 19, Sgt. Rob Nederlof pedalled the highways between Edmonton and Regina on his bike. This was the fourth year for the ride, which...
Les derniers communiqués
-
Villeroy & Boch joins the ranks of Europe's largest manufacturers of bathroom products
Villeroy & Boch - 01/03/2024